BIOTRONIK - SaFety and Performance Registry for an All-comers Patient Population With the Limus Eluting Orsiro Stent System Within Daily Clinical Practice - III United Kingdom Satellite
Phase of Trial: Phase IV
Latest Information Update: 22 Sep 2016
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- Sponsors BIOTRONIK
- 29 Aug 2016 Status changed from not yet recruiting to recruiting.
- 09 Sep 2015 According to the ClinicalTrials.gov record, planned initiation date changed from 1 Nov 2014 to 1 Oct 2015.
- 09 Oct 2014 New trial record